Browse by Title

Type here to filter the list

S
Safety and Analgesic Effect of the TRPV1 Agonist RTX-GRT7039 in Osteoarthritis Knee Pain (P-022)
Favorite

Lizandra Marcondes, MD, PhD – Averitas ### 2434716###Author/Presenter###VP of Medical Affairs###Averitas###
Author/Presenter: Lizandra Marcondes, MD, PhD – Averitas
### @@@ Thor Ostenfeld, PhD, MBA – Grünenthal ### 2434745###Author/Presenter###Head of Clinical Development###Grünenthal###
Author/Presenter: Thor Ostenfeld, PhD, MBA – Grünenthal
### @@@ Christoph Eibl, PhD – Grünenthal ### 2434746###Author/Presenter###Global Safety Lead###Grünenthal###
Author/Presenter: Christoph Eibl, PhD – Grünenthal
### @@@ Nicola Young, PharmD – Grünenthal ### 2434747###Author/Presenter###Global Safety Scientist###Grünenthal###
Author/Presenter: Nicola Young, PharmD – Grünenthal
### @@@ Stefan Ivanavicius, PhD – Grünenthal ### 2434749###Author/Presenter###Senior Director, Global Medical Lead, RTX###Grünenthal###
Author/Presenter: Stefan Ivanavicius, PhD – Grünenthal
### P-022
Safety and Efficacy of Wharton’s Jelly Connective Tissue Allograft for Rotator Cuff Tears: Findings from a Retrospective Observational Study (P-096)
Favorite

Albert Lai, MD – Desert Pain Specialists ### 2434798###Author/Presenter###Medical Director###Desert Pain Specialists###
Author/Presenter: Albert Lai, MD – Desert Pain Specialists
### @@@ Conrad Tamea, MD – Biohealing Wellness ### 2434848###Author/Presenter###Owner and Chief Medical Director###Biohealing Wellness###
Author/Presenter: Conrad Tamea, MD – Biohealing Wellness
### @@@ Naomi Lambert, BS – Regenative Labs ### 2099239###Author/Presenter###Clinical Site Coordinator###Regenative Labs###
Author/Presenter: Naomi Lambert, BS – Regenative Labs
### P-096
Safety and Tolerability of Schedule III Buprenorphine and Oral Schedule II Opioid Treatment in Chronic Low Back Pain Patients: A Retrospective US Medicare Claims Analysis (P-018)
Favorite

Dimitrije Grbic, PhD (c) – ZRx Outcomes Research Inc. ### 2099142###Author/Presenter###Senior Research Analyst###ZRx Outcomes Research Inc.###
Author/Presenter: Dimitrije Grbic, PhD (c) – ZRx Outcomes Research Inc.
### @@@ Filip Stanicic, MSc – ZRx Outcomes Research Inc. ### 2099139###Author/Presenter###HEOR Partner###ZRx Outcomes Research Inc.###
Author/Presenter: Filip Stanicic, MSc – ZRx Outcomes Research Inc.
### @@@ Vladimir Zah, PhD – ZRx Outcomes Research inc. ### 2099138###Author/Presenter###Chief Science Officer###ZRx Outcomes Research inc.###
Author/Presenter: Vladimir Zah, PhD – ZRx Outcomes Research inc.
### P-018
Satisfaction with treatment outcomes in people with migraine receiving rimegepant or triptans: a descriptive analysis from a real-world migraine tracking app (P-103)
Favorite

Lucy Abraham, Msc – Pfizer R&D UK Ltd., Tadworth, Surrey ### 2099237###Author/Presenter###Senior Director, HV&E Team Lead, Migraine###Pfizer R&D UK Ltd., Tadworth, Surrey###
Author/Presenter: Lucy Abraham, Msc – Pfizer R&D UK Ltd., Tadworth, Surrey
### @@@ Karin Hygge Blakeman, PhD – Pfizer ### 2099240###Author/Presenter###Medical Director###Pfizer###
Author/Presenter: Karin Hygge Blakeman, PhD – Pfizer
### @@@ Feng Dai, PhD – Pfizer Inc. ### 2434744###Author/Presenter###Director of Biostatistics###Pfizer Inc.###
Author/Presenter: Feng Dai, PhD – Pfizer Inc.
### @@@ Boryana Galabova, MSc – Pfizer R&D UK Ltd ### 2434772###Author/Presenter###Research Associate###Pfizer R&D UK Ltd###
Author/Presenter: Boryana Galabova, MSc – Pfizer R&D UK Ltd
### @@@ Martin Ho, MSc – Pfizer Inc ### 2434773###Author/Presenter###Senior Director of RWE Strategy###Pfizer Inc###
Author/Presenter: Martin Ho, MSc – Pfizer Inc
### @@@ Maria Kontou, PhD – Pfizer GmbH ### 2434774###Author/Presenter###Sr. Clinical Scientist###Pfizer GmbH###
Author/Presenter: Maria Kontou, PhD – Pfizer GmbH
### @@@ Alexandre Urani, PhD – Aptar Digital Health ### 2434771###Author/Presenter###Head of Clinical product development###Aptar Digital Health###
Author/Presenter: Alexandre Urani, PhD – Aptar Digital Health
### P-103
Severity risk assessment of opioid-induced respiratory depression or overdose in patients with cancer (P-003)
Favorite

Parker K. Kaleo, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego ### 2434637###Author/Presenter###Student###Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego###
Author/Presenter: Parker K. Kaleo, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego
### @@@ Norint P. Tung, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego ### 2434638###Author/Presenter###Fellow###Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego###
Author/Presenter: Norint P. Tung, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego
### @@@ Joseph D. Ma, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego ### 2434636###Author/Presenter###Professor, Division of Clinical Pharmacy###Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego###
Author/Presenter: Joseph D. Ma, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego
### P-003
Shoulder Pain Management for Patients: A Mobile Application for Interventional Pain Options (P-123)
Favorited

Michael Shafer, MSN, CRNA – Middle Tennessee School of Anesthesia ### 2434710###Author/Presenter###Certified Registered Nurse Anesthetist###Middle Tennessee School of Anesthesia###
Author/Presenter: Michael Shafer, MSN, CRNA – Middle Tennessee School of Anesthesia
### @@@ Nicholai Mathewson, MSN, CRNA – Middle Tennessee School of Anesthesia ### 2434711###Author/Presenter###Certified Registered Nurse Anesthetist###Middle Tennessee School of Anesthesia###
Author/Presenter: Nicholai Mathewson, MSN, CRNA – Middle Tennessee School of Anesthesia
### @@@ Jordan Scott, MSN, CRNA – Middle Tennessee School of Anesthesia ### 2434712###Author/Presenter###Certified Registered Nurse Anesthetist###Middle Tennessee School of Anesthesia###
Author/Presenter: Jordan Scott, MSN, CRNA – Middle Tennessee School of Anesthesia
### @@@ James Hilfiger, MSN, CRNA – Middle Tennessee School of Anesthesia ### 2434713###Author/Presenter###Certified Registered Nurse Anesthetist###Middle Tennessee School of Anesthesia###
Author/Presenter: James Hilfiger, MSN, CRNA – Middle Tennessee School of Anesthesia
### @@@ Ileana Izquierdo, MSN, CRNA – Middle Tennessee School of Anesthesia ### 2434714###Author/Presenter###Certified Registered Nurse Anesthetist###Middle Tennessee School of Anesthesia###
Author/Presenter: Ileana Izquierdo, MSN, CRNA – Middle Tennessee School of Anesthesia
### @@@ Hallie Evans, DNP, CRNA, APRN, CNE – Middle Tennessee School of Anesthesia ### 2434715###Author/Presenter###Director Doctoral Completion Program and Nurse Educator Track###Middle Tennessee School of Anesthesia###
Author/Presenter: Hallie Evans, DNP, CRNA, APRN, CNE – Middle Tennessee School of Anesthesia
### P-123
Significance of Morphine Milligram Equivalents in the 5 Days Prior to Acute Inpatient Rehabilitation Stay (P-088)
Favorite

Sierra R. McLean, MD – University of North Carolina ### 2434645###Author/Presenter###Resident###University of North Carolina###
Author/Presenter: Sierra R. McLean, MD – University of North Carolina
### @@@ Dennis A. Jallah, III, n/a – UNCSOM ### 2434646###Author/Presenter###Medical Student###UNCSOM###
Author/Presenter: Dennis A. Jallah, III, n/a – UNCSOM
### @@@ Lee T. Shuping, MD, MPT – University of North Carolina, Dept of PM&R ### 2434647###Author/Presenter###Clinical Assistant Professor###University of North Carolina, Dept of PM&R###
Author/Presenter: Lee T. Shuping, MD, MPT – University of North Carolina, Dept of PM&R
### P-088
Single center, retrospective analysis to predict opioid-induced oversedation and respiratory depression utilizing a modified Oversedation Risk Criteria score in patients with cancer (P-004)
Favorite

Norint P. Tung, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego ### 2434638###Author/Presenter###Fellow###Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego###
Author/Presenter: Norint P. Tung, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego
### @@@ Parker K. Kaleo, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego ### 2434637###Author/Presenter###Student###Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego###
Author/Presenter: Parker K. Kaleo, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego
### @@@ Joseph D. Ma, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego ### 2434636###Author/Presenter###Professor, Division of Clinical Pharmacy###Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego###
Author/Presenter: Joseph D. Ma, PharmD – Skaggs School of Pharmacy & Pharmaceutical Sciences, UC San Diego
### P-004
Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Case Series (P-097)
Favorite

Ryan Robinson, DDS – Pain and Sleep Therapy Center ### 2099290###Author/Presenter###Owner and Chief Medical Director###Pain and Sleep Therapy Center###
Author/Presenter: Ryan Robinson, DDS – Pain and Sleep Therapy Center
### @@@ Rachel Reynolds, FNP – Pain and Sleep Therapy Center ### 2099291###Author/Presenter###FNP and Certified Nutritionist###Pain and Sleep Therapy Center###
Author/Presenter: Rachel Reynolds, FNP – Pain and Sleep Therapy Center
### @@@ Naomi Lambert, BS – Regenative Labs ### 2099239###Author/Presenter###Clinical Site Coordinator###Regenative Labs###
Author/Presenter: Naomi Lambert, BS – Regenative Labs
### P-097
SMART™ Opioids with Unprecedented Protection Against Abuse and Oral Overdose – Human Proof-of-Concept (P-081)
Favorited

Thomas E. Jenkins, Ph.D. – Elysium Therapeutics, Inc. ### 2434788###Author/Presenter###CSO / EVP###Elysium Therapeutics, Inc.###
Author/Presenter: Thomas E. Jenkins, Ph.D. – Elysium Therapeutics, Inc.
### @@@ Lynn R. Webster, MD – Dr. Vince Clinical Research ### 1089075###Author/Presenter###Executive Vice President Scientific Affairs###Dr. Vince Clinical Research###
Author/Presenter: Lynn R. Webster, MD – Dr. Vince Clinical Research
### @@@ Leela Vrishabhendra, MD – MedPace, Inc. ### 2434789###Author/Presenter###Senior Medical Director###MedPace, Inc.###
Author/Presenter: Leela Vrishabhendra, MD – MedPace, Inc.
### @@@ Greg Sturmer, n/a – Elysium Therapeutics ### 2434790###Author/Presenter###CEO###Elysium Therapeutics###
Author/Presenter: Greg Sturmer, n/a – Elysium Therapeutics
### P-081
Study design for testing safety, tolerability, and efficacy of NTM-006 against pain symptoms associated with Fragile X Tremor/Ataxia Syndrome (FXTAS) (P-014)
Favorite

Robert B. Raffa, PhD (he/him/his) – Visual and Autonomous Exploration Systems Research Laboratory, University of Arizona, Tucson ### 1089108###Author/Presenter###Adjunct###Visual and Autonomous Exploration Systems Research Laboratory, University of Arizona, Tucson###
Author/Presenter: Robert B. Raffa, PhD (he/him/his) – Visual and Autonomous Exploration Systems Research Laboratory, University of Arizona, Tucson
### he/him/his @@@ Krista Casazza, PHD, RD – NEMA RESEARCH ### 2434611###Author/Presenter###SCIENTIFIC CONSULTANT###NEMA RESEARCH###
Author/Presenter: Krista Casazza, PHD, RD – NEMA RESEARCH
### @@@ Joseph V. Pergolizzi, Jr., MD – NMEA Research, Inc. ### 1441220###Author/Presenter###COO###NMEA Research, Inc.###
Author/Presenter: Joseph V. Pergolizzi, Jr., MD – NMEA Research, Inc.
### @@@ Randi J. Hagerman, MD – UC Davis Health ### 2434671###Author/Presenter###Distinguished Professor###UC Davis Health###
Author/Presenter: Randi J. Hagerman, MD – UC Davis Health
### @@@ Paul J. Hagerman, MD, PhD – UC Davis ### 2434672###Author/Presenter###Distinguished Professor###UC Davis###
Author/Presenter: Paul J. Hagerman, MD, PhD – UC Davis
### @@@ Amanjot K. Batra, BA – Neumentum ### 2434695###Author/Presenter###Clinical Research Associate###Neumentum###
Author/Presenter: Amanjot K. Batra, BA – Neumentum
### @@@ Lesa Deonarine, MBA – Neumentum ### 2434696###Author/Presenter###Consultant###Neumentum###
Author/Presenter: Lesa Deonarine, MBA – Neumentum
### @@@ Joseph M. Scavone, Pharm.D., M.S., M.B.A., M.Sc. – Temple University School of Pharmacy and Tufts University School of Medicine ### 2434809###Author/Presenter###Consultant and Head of Clinical Operations and Regulatory Affairs###Temple University School of Pharmacy and Tufts University School of Medicine###
Author/Presenter: Joseph M. Scavone, Pharm.D., M.S., M.B.A., M.Sc. – Temple University School of Pharmacy and Tufts University School of Medicine
### P-014
Subcutaneous Opioids: Under the Skin Irritation or New Standard of Care? (P-064)
Favorited

Alexis Beachy, PharmD – OhioHealth ### 2434775###Author/Presenter###Palliative Care Pharmacist###OhioHealth###
Author/Presenter: Alexis Beachy, PharmD – OhioHealth
### @@@ Natalie Malone, PharmD – OhioHealth ### 2434776###Author/Presenter###Palliative Care Pharmacist###OhioHealth###
Author/Presenter: Natalie Malone, PharmD – OhioHealth
### @@@ Lynn Aung, PharmD – OhioHealth ### 2434777###Author/Presenter###Palliative Care Pharmacist###OhioHealth###
Author/Presenter: Lynn Aung, PharmD – OhioHealth
### @@@ Zak Tressel, PharmD – OhioHealth ### 2434779###Author/Presenter###Internal Medicine Pharmacist###OhioHealth###
Author/Presenter: Zak Tressel, PharmD – OhioHealth
### @@@ Amy Durell, PharmD – OhioHealth ### 2434778###Author/Presenter###Emergency Medicine Pharmacist###OhioHealth###
Author/Presenter: Amy Durell, PharmD – OhioHealth
### @@@ Tommy Petros, MD – OhioHealth ### 2434780###Author/Presenter###Palliative Medicine Physician###OhioHealth###
Author/Presenter: Tommy Petros, MD – OhioHealth
### @@@ Kerry Bertke, DO – OhioHealth ### 2434781###Author/Presenter###Palliative Medicine Physician###OhioHealth###
Author/Presenter: Kerry Bertke, DO – OhioHealth
### P-064